Literature DB >> 8640453

Antisense manganese superoxide dismutase mRNA inhibits the antiviral action of interferon-gamma and interferon-alpha.

I Raineri1, T T Huang, C J Epstein, L B Epstein.   

Abstract

Manganese superoxide dismutase (MnSOD) is induced by interferon-gamma (IFN-gamma) in various cell lines. To determine whether MnSOD plays a role in the antiviral action of IFN-gamma, we employed an antisense strategy to inhibit the expression of MnSOD in the human melanoma cell line, A375. Three antisense-containing clones that exhibited reduced induction of MnSOD were investigated with respect to their response to the antiviral protective effects of IFN-gamma and IFN-alpha. We observed a striking decrease in the ability of IFN-gamma to protect antisense clones from vesicular stomatitis virus infection (VSV). The IFN-alpha induced antiviral state was also impaired, but to a lesser degree than was observed with IFN-gamma. We excluded the possibility that these effects were caused by a higher sensitivity of the antisense cells to VSV itself and found that the antisense clones actually were less sensitive to VSV. Therefore, we conclude that MnSOD is involved in the establishment of the IFN-gamma-induced antiviral state and to a lesser degree in the antiviral actions of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640453     DOI: 10.1089/jir.1996.16.61

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  2 in total

1.  Metabolic regulation of manganese superoxide dismutase expression via essential amino acid deprivation.

Authors:  Kimberly J Aiken; Justin S Bickford; Michael S Kilberg; Harry S Nick
Journal:  J Biol Chem       Date:  2008-01-10       Impact factor: 5.157

2.  Experimental autoimmune encephalomyelitis (EAE) up-regulates the mitochondrial activity and manganese superoxide dismutase (MnSOD) in the mouse renal cortex.

Authors:  Balamurugan Packialakshmi; Xiaoming Zhou
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.